From May 20 to 22, the 64th National Pharmaceutical Machinery Exposition was held at Qingdao World Expo City. "Empowering High-Quality Development through the Development of New Quality Productive Forces" has become the primary theme across various industries, aimed at addressing the fluctuations of the global economy and industrial cycles. As an integral and vital component of the pharmaceutical sector, the pharmaceutical equipment industry shoulders the mission of collectively promoting high-quality industry development.

Exhibition highlights

Morimatsu consistently stays ahead of new market developments, continually upgrading its R&D technology. At this exhibition, Morimatsu showcased a range of outstanding products and presented five major solutions, attracting the attention of numerous visitors.

Offering upstream culture solution, downstream separation and purification solution, and disposable system solution, Morimatsu enhances customers' R&D efficiency, accelerates the innovation and implementation of therapeutic solutions, ultimately bringing more benefits to patients.

The Mini-MD Fluidized Bed is equipped with easily interchangeable product pot modules, enabling multifunctional granulation, drying, and coating operations on a single machine. This ensures flexibility for product development and process improvement.

The WD Multifunctional Filter Dryer (3-in-1) is an innovative piece of equipment that enhances station switching functionality. It optimally utilizes filtration, washing, drying, and discharging functions, consolidating multiple process steps into one machine for enhanced convenience in operation.

Morimatsu's modular plant offers a turnkey total solution from design to validation, saving time in constructing new factory buildings and significantly reducing on-site construction. This enables overall off-site relocation of the building, meeting pharmaceutical companies' needs for rapid product launches and flexible production expansion.

Utilizing VR simulation technology, we break free from the constraints of traditional training processes such as time and space. Our simulations recreate real-world operations, significantly reducing training costs and time while enhancing training efficiency.

Morimatsu and industry leaders convened for an in-depth dialogue and exchange on the challenges and opportunities facing the industry. Sharing cutting-edge technology and exploring opportunities for collaboration, we collectively strive for new breakthroughs and growth opportunities.

As a trailblazer in the pharmaceutical equipment sector, Morimatsu seizes every pivotal development opportunity to establish a new industry standard. Committed to enhancing customer efficiency and production quality, we continuously research and develop cutting-edge technology tailored to their actual needs. Cooperate for Shared Success and Bright Future In the future, Morimatsu will continue to integrate advantageous resources, deepen practical cooperation, honor the trust and choice of our customers, and empower the high-quality development of the industry.

About Morimatsu LifeSciences

Morimatsu LifeSciences, one of the key business segments of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), mainly consists of Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Company Limited, Shanghai Morimatsu Biotechnology Co., Ltd., Pharmadule Morimatsu AB (Sweden) and its subsidiaries, which serves the pharmaceuticals, bio-pharmaceutical, cosmetic medicine, FMCG (cosmetics, baby, women & home Care, health care, fabric & home care, food, beverage, nutraceuticals) and other industries, providing customers with "core equipment+value-added services+digital intelligent overall factory solutions and services" ("MVP Solutions&Services"), focusing on core equipment, stainless steel process systems, disposable process systems, consumables, laboratory solutions, digital and modular factory solutions and services.

As a diversified multinational company, Morimatsu has opened subsidiaries or advanced manufacturing plants in China, Japan, Sweden, United States, India, Italy, Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by its global footprint of an efficient and professional team.

Forward-Looking Statements

The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of "predicted", "believed", "forecast", "planned" and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our Company undertakes no obligation to constantly revise such predicted statements.

Forward-looking statements are based on our Company management's current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guarantees of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our Company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.